Morgan Stanley Neovasc Inc Transaction History

Morgan Stanley

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$15.81 - $29.88 $10,023 - $18,943	-634 Reduced 17.44%	3,001 $87,000
Q4 2022 Feb 14, 2023	SELL	$6.5 - $16.05 $6,142 - $15,167	-945 Reduced 20.63%	3,635 $57,000
Q3 2022 Nov 14, 2022	BUY	$5.95 - $7.93 $18,772 - $25,019	3,155 Added 221.4%	4,580 $31,000
Q2 2022 Aug 15, 2022	BUY	$4.9 - $10.75 $6,982 - $15,318	1,425 New	1,425 $9,000

Ticker NVCN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 2,743,140
Description
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly kn...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.